UK markets closed

Swedish Orphan Biovitrum AB (publ) (0MTD.L)

LSE - LSE Delayed price. Currency in SEK
Add to watchlist
215.00-9.04 (-4.03%)
At close: 04:57PM GMT
Currency in SEK

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.23
52-week change 3N/A
S&P500 52-week change 326.89%
52-week high 3220.30
52-week low 3212.20
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 8198.59M
% held by insiders 18.81%
% held by institutions 173.98%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 10.89%
Operating margin (ttm)25.04%

Management effectiveness

Return on assets (ttm)4.46%
Return on equity (ttm)7.98%

Income statement

Revenue (ttm)22.12B
Revenue per share (ttm)68.57
Quarterly revenue growth (yoy)14.30%
Gross profit (ttm)N/A
EBITDA 7.72B
Net income avi to common (ttm)2.41B
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)-26.00%

Balance sheet

Total cash (mrq)904M
Total cash per share (mrq)2.66
Total debt (mrq)20.48B
Total debt/equity (mrq)60.49%
Current ratio (mrq)0.66
Book value per share (mrq)99.68

Cash flow statement

Operating cash flow (ttm)4.47B
Levered free cash flow (ttm)-325.25M